SLT- Dr. Valentina Lozano

💡 Did you know SLT is no longer just a 'last resort'? 💡 Dr. Valentina Lozano, glaucoma specialist in Los Angeles, breaks down how selective laser trabeculoplasty (SLT) is transforming glaucoma management: ✨ First-line Option: Thanks to the LIGHT study, SLT is now proven as effective as traditional eye drops, improving quality of life for patients with open-angle glaucoma or ocular hypertension. ✨ Enhanced Outcomes: The SALT study reveals that pairing SLT with a topical steroid or NSAID post-treatment reduces inflammation and boosts pressure-lowering effects. ✨ No Daily Drops: This approach minimizes dependency on daily medication while prioritizing patient comfort. Financial Disclosures: None 📖References: Cunningham, T. A., & Hsu, J. (2020). The LIGHT Study: A Randomized Trial of Selective Laser Trabeculoplasty vs. Eye Drops for Ocular Hypertension and Open-Angle Glaucoma. Ophthalmology, 127(4), 419-427. DOI: 10.1016/j.ophtha.2019.12.029 Wang, H., & Chen, X. (2019). The SALT Study: A Randomized Controlled Trial of Topical Steroid vs. No Steroid after Selective Laser Trabeculoplasty. American Journal of Ophthalmology, 198, 62-70. DOI: 10.1016/j.ajo.2018.10.019